United Theranostics
PrivateLast Round
Early Funding
Jan 26, 2026
Total Funding Raised
$15M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
United Theranostics operates in Healthcare & Life Sciences and is based in Bethesda, Maryland. Its latest recorded funding round was an Early Funding round in January 2026.
United Theranostics is a healthcare company that provides molecular imaging and precision radiopharmaceutical therapy services for the treatment of complex cancers.
Sector
Healthcare & Life Sciences
Verticals
Medical Imaging, Precision Medicine, Biotechnology, Clinical Trials
Business Model
B2C
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
United Theranostics Comparables
Compare United Theranostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Theranostics Centers of America | 90% | |
| BAMF Health | 84% | |
| McKesson | 75% |
For institutional investors. Book with your work email.
United Theranostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Jan 26, 2026 | ||||
| Debt | Feb 11, 2025 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
United Theranostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Courage Capital Management | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 2, 2026
Open roles increased to 28, 64% of headcount.
- Apr 25, 2026
Grew 16% QoQ, from 37 to 43 employees.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- hiresOct 29, 2026
United Theranostics appoints Amber Woodward-Smith as Chief Financial Officer to support nationwide expansion of its outpatient cancer treatment center network in Maryland on Oct 29th '26.
For institutional investors. Book with your work email.
United Theranostics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about United Theranostics's valuation, stock price, and market status.
Is United Theranostics a public or private company?
United Theranostics is a private company.
What is the current stock price of United Theranostics?
United Theranostics is a private company, so its shares have no public market price. Caplight tracks United Theranostics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is United Theranostics worth (valuation)?
Valuation information for United Theranostics is not publicly available.
Can I buy United Theranostics stock?
United Theranostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was United Theranostics's last funding round?
United Theranostics's most recent funding round was Early Funding on January 26, 2026.
Who are the main investors in United Theranostics?
Key investors in United Theranostics include Courage Capital Management.
Will United Theranostics IPO soon?
No public IPO plans have been announced for United Theranostics.
How can I track United Theranostics secondary market activity?
Caplight tracks bids, offers, and trades in United Theranostics's shares on secondary markets.